Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -116.60% is 85% below its 5-year average of -63.10%, near the low end of its 5-year range (-116.60%–-31.01%).
75.93% below its 12-month average of -66.28%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -32.49%.
RETURN ON ASSETS (ROA)
-116.60%
RETURN ON ASSETS (ROA) AVG TTM
-66.28%
RETURN ON ASSETS (ROA) AVG 3Y
-71.56%
RETURN ON ASSETS (ROA) AVG 5Y
-63.10%
RETURN ON ASSETS (ROA) AVG 10Y
-30.77%
RETURN ON ASSETS (ROA) AVG 15Y
-28.64%
RETURN ON ASSETS (ROA) AVG 20Y
-37.01%
CURRENT VS TTM AVG
-75.93%
CURRENT VS 3Y AVG
-62.95%
CURRENT VS 5Y AVG
-84.79%
CURRENT VS 10Y AVG
-278.94%
CURRENT VS 15Y AVG
-307.16%
CURRENT VS 20Y AVG
-215.07%
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 560 covered companies
CURRENT VS SECTOR MEDIAN
-315.76%
vs the sector median at left
Dyadic International, Inc.
Market Cap
$16.87M
Return on Assets (ROA)
-116.60%
TTM Avg
-66.28%
3Y Avg
-71.56%
5Y Avg
-63.10%
Market Cap
$16.74M
Return on Assets (ROA)
-67.58%
TTM Avg
-90.98%
3Y Avg
-83.38%
5Y Avg
-70.12%
Market Cap
$17.19M
Return on Assets (ROA)
-49.72%
TTM Avg
-28.29%
3Y Avg
-39.08%
5Y Avg
-40.04%
Market Cap
$16.43M
Return on Assets (ROA)
-154.34%
TTM Avg
-227.23%
3Y Avg
-240.86%
5Y Avg
-184.63%
Market Cap
$17.76M
Return on Assets (ROA)
-59.70%
TTM Avg
-56.25%
3Y Avg
-61.89%
5Y Avg
-61.99%
Market Cap
$15.75M
Return on Assets (ROA)
-38.41%
TTM Avg
-84.87%
3Y Avg
-95.12%
5Y Avg
-75.66%
Market Cap
$15.44M
Return on Assets (ROA)
-213.77%
TTM Avg
-110.51%
3Y Avg
-93.41%
5Y Avg
-68.22%
Market Cap
$15.39M
Return on Assets (ROA)
-41.18%
TTM Avg
-60.23%
3Y Avg
-53.11%
5Y Avg
-40.22%
Market Cap
$15.18M
Return on Assets (ROA)
-201.89%
TTM Avg
-113.65%
3Y Avg
-83.24%
5Y Avg
-72.72%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dyadic International, Inc. (DYAI) | $16.87M | -116.60% | -66.28% | -71.56% | -63.10% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.74M | -67.58% | -90.98% | -83.38% | -70.12% |
| Lipocine Inc. (LPCN)vs › | $17.19M | -49.72% | -28.29% | -39.08% | -40.04% |
| BioCardia, Inc. (BCDA)vs › | $16.43M | -154.34% | -227.23% | -240.86% | -184.63% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.76M | -59.70% | -56.25% | -61.89% | -61.99% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.75M | -38.41% | -84.87% | -95.12% | -75.66% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.44M | -213.77% | -110.51% | -93.41% | -68.22% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.39M | -41.18% | -60.23% | -53.11% | -40.22% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.18M | -201.89% | -113.65% | -83.24% | -72.72% |
| Cosmos Health Inc. (COSM)vs › | $19.02M | -39.68% | -29.52% | -26.86% | -20.28% |
ROA
-116.6%
ROE
N/A
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -74.05% |
| 2024-12-31 | -58.50% |
| 2023-12-31 | -82.68% |
| 2022-12-31 | -70.99% |
| 2021-12-31 | -61.37% |
| 2020-12-31 | -31.01% |
| 2019-12-31 | -22.18% |
| 2018-12-31 | -13.14% |
| 2017-12-31 | -4.21% |
| 2016-12-31 | -6.15% |
| 2015-12-31 | 85.81% |
| 2014-12-31 | -70.06% |
| 2013-12-31 | -2.87% |
| 2012-12-31 | 10.48% |
| 2006-12-31 | -24.11% |
| 2005-12-31 | -44.27% |
| 2004-12-31 | -18.58% |
| 2003-12-31 | -1157.44% |
